February 20, 2014

Research Roundup: What we’re reading this week

Senior Program Assistant

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

A new report sponsored by the Bill & Melinda Gates Foundation examines the need for post-market surveillance for new drugs and vaccines in low- and middle-income countries. The report is based off the findings from the Safety Surveillance Working Group, and provides recommendations stakeholders should take to strengthen post-market surveillance of global health products.

The University of South Florida’s Center for Drug Development and Innovation, and the College of Public Health’s Department of Global Health have been awarded a grant of $2.1 million from the National Institutes of Health. The focus of the research will be to see how parasites, like malaria, grow.

At a recent event in Washington, DC, US Agency for International Development (USAID) Administrator Rajiv Shah underscored the agency’s commitment to public-private partnerships. According to Devex, 40 percent of USAID’s resources are programmed through public-private partnerships.

New studies show that patients with multidrug-resistant tuberculosis (TB) and HIV/AIDS have a higher chance of living if they take simultaneous treatment for both diseases, as oppose to waiting to take HIV/AIDS treatment. The initial study was small in size, but concurs with three previous major studies of people with regular TB and HIV/AIDS.